Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

438508

registered interest
date	15/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Action on Smoking and Health
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the role of Action on Smoking and Health in providing the secretariat to the All Party Parliamentary Group on Smoking and Health, and in particular whether such activities are designed to influence (1) Parliament, Government or political parties, or (2) legislative or regulatory action.
tabling member printed	Lord Naseby
uin	HL4604
answer	answer is ministerial correction date of answer 17/12/2015 answer text <p>The Department has made no assessment of the role of Action on Smoking and Health (ASH) in providing the secretariat to the All Party Parliamentary Group on Smoking and Health.</p><br /><p>The conditions applicable to grants awarded to ASH for work to support tobacco control are set out in the grant award letters. The Department has made clear that none of this funding is to be used for activities designed to influence Parliament, Government or political parties or to influence legislative or regulatory action. ASH’s compliance with the conditions of the grant is assessed at grant monitoring meetings as well as in the final full year grant monitoring and governance reports.</p> answering member printed Lord Prior of Brampton question first answered 17/12/2015 17:19:06 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	1251 label Biography information for Lord Naseby

437870

registered interest
date	14/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Smoking
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how they intend to reduce smoking within the NHS as part of implementing "the radical upgrade in prevention and public health" called for in NHS England’s Five Year Forward View.
tabling member printed	Lord Young of Cookham
uin	HL4572
answer	answer is ministerial correction date of answer 17/12/2015 answer text <p>Smoking continues to be the leading cause of premature death and health inequality in England, placing a significant burden on the National Health Service.</p><br /><p>The Department remains dedicated to the delivery of effective and robust tobacco control and has committed to developing a new tobacco control strategy to further reduce the prevalence of smoking, working with NHS England and Public Health England (PHE) to identify interventions that will make the best contributions to achieving this.</p><br /><p>Training material and guidance has been developed to support health professionals deliver effective interventions to pregnant women who smoke.</p><p><strong></strong></p><p>PHE will continue to support local authorities by developing and distributing information and advice for the commissioning of effective smoking cessation services.</p> answering member printed Lord Prior of Brampton question first answered 17/12/2015 17:20:25 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	57 label Biography information for Lord Young of Cookham

437891

registered interest
date	14/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hospitals: Admissions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people were (a) admitted to hospital and (b) attended A&E on grounds relating to (i) alcohol and (ii) obesity in each of the last five years.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	19900
answer	answer is ministerial correction date of answer 17/12/2015 answer text <br /><p>We are unable to provide the number of people who attended accident and emergency (A&amp;E) on grounds relating to alcohol or obesity as the A&amp;E diagnosis does not record this level of detail.</p><br /><p>The following table contains the sum of the estimated partly and wholly attributable alcohol fractions of all finished admission episodes (FAEs) for years 2009-10 to 2013-14. Alcohol fraction data is not yet available for the latest year of published data (2014-15) therefore we have provided figures for the five years from 2009-10 to 2013-14.</p><br /><p>Sum of partly and wholly attributable alcohol fractions<sup>1</sup> of finished admission episodes (FAEs)<sup>2</sup>, using broad<sup>3</sup> and narrow<sup>4</sup> measures for 2009-10 to 2013-14<sup>5</sup></p><table><tbody><tr><td colspan="5"><p>Alcohol attributable admissions</p></td></tr><tr><td><p>Year</p></td><td colspan="2"><p>Broad measure</p></td><td colspan="2"><p>Narrow measure</p></td></tr><tr><td><p><br></p></td><td><p>Partly</p></td><td><p>Wholly</p></td><td><p>Partly</p></td><td><p>Wholly</p></td></tr><tr><td><p>2009-10</p></td><td><p>607,400</p></td><td><p>267,070</p></td><td><p>216,760</p></td><td><p>101,870</p></td></tr><tr><td><p>2010-11</p></td><td><p>670,250</p></td><td><p>288,750</p></td><td><p>223,300</p></td><td><p>105,170</p></td></tr><tr><td><p>2011-12</p></td><td><p>693,810</p></td><td><p>305,730</p></td><td><p>224,910</p></td><td><p>106,680</p></td></tr><tr><td><p>2012-13</p></td><td><p>711,840</p></td><td><p>297,010</p></td><td><p>222,700</p></td><td><p>103,160</p></td></tr><tr><td><p>2013-14</p></td><td><p>751,500</p></td><td><p>307,710</p></td><td><p>225,190</p></td><td><p>107,820</p></td></tr></tbody></table><table><tbody><tr><td><p>Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector <br> Source: Hospital Episode Statistics (HES), Health and Social Care Information Centre</p></td></tr></tbody></table><br /><p>We have also provided a table containing the count of finished FAEs with a primary diagnosis of Obesity for the years from 2010-11 to 2014-15.</p><p>A primary diagnosis is the main reason a patient was admitted to hospital, so this count would not include patients with specific conditions that are made more likely by obesity unless the obesity itself was the main reason for the admission.</p><br /><p>Count of FAEs<sup>2</sup> with a primary diagnosis<sup>6</sup> of Obesity<sup>7</sup>, 2010-11 to 2014-15<sup>5</sup></p><table><tbody><tr><td><p>Year</p></td><td><p>Obesity Admissions</p></td></tr><tr><td><p>2010-11</p></td><td><p>11,740</p></td></tr><tr><td><p>2011-12</p></td><td><p>11,905</p></td></tr><tr><td><p>2012-13</p></td><td><p>11,091</p></td></tr><tr><td><p>2013-14</p></td><td><p>9,462</p></td></tr><tr><td><p>2014-15</p></td><td><p>9,520</p></td></tr></tbody></table><p>Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector</p><p>Source: Hospital Episode Statistics (HES), Health and Social Care Information Centre</p><p><em>Notes:</em></p><p>[1]Alcohol-related admissions</p><p>The number of alcohol-related admissions is based on the methodology developed by the North West Public Health Observatory (NWPHO), which uses 48 indicators for alcohol-related illnesses, determining the proportion of a wide range of diseases and injuries that can be partly attributed to alcohol as well as those that are, by definition, wholly attributable to alcohol. Further information on these proportions can be found at</p><p>http://www.nwph.net/nwpho/publications/AlcoholAttributableFractions.pdf</p><p>The alcohol attributable fraction is set to 1 (100%) where the admission is considered to be entirely due to alcohol, e.g. in the case of alcoholic liver disease - these records are described as wholly alcohol attributable.</p><p>The alcohol attributable fraction is set to a value greater than 0 but less than 1 according to the NWPHO definition, e.g. the alcohol fraction of an admission with a primary diagnosis of C00 - malignant neoplasm of lip, where the patient is male and between 65 and 74 is 0.44 - these records are described as partly alcohol attributable.</p><p>These wholly and partly attributable fractions can be aggregated to supply an estimate of activity which can be considered wholly or partly attributable to alcohol.</p><p>Partly alcohol attributable fractions are not applicable to children under 16. Therefore figures for this age group relate only to wholly-attributable admissions, where the attributable fraction is one.</p><p>The application of the NWPHO methodology has recently been updated but is not currently available from HES.</p><br /><p>[2]Finished admission episodes</p><p>A finished admission episode (FAE) is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.</p><br /><p>[3]Broad measure</p><p>Broad measure – derived by summing the alcohol attributable fraction associated with each admission based on the diagnosis most strongly associated with alcohol out of all diagnoses (both primary and secondary).</p><br /><p>[4]Narrow measure</p><p>Narrow measure – is constructed in a similar way but counts only the fraction associated with the diagnosis in the primary position or alcohol-related external causes recorded in secondary diagnosis fields.</p><br /><p>[5]Assessing growth through time (Admitted patient care)</p><p>HES figures are available from 1989-90 onwards. Changes to the figures over time need to be interpreted in the context of improvements in data quality and coverage (particularly in earlier years), improvements in coverage of independent sector activity (particularly from 2006-07) and changes in NHS practice. For example, changes in activity may be due to changes in the provision of care.</p><br /><p>[6]Primary diagnosis</p><p>The primary diagnosis is the first of up to 20 (14 from 2002-03 to 2006-07 and 7 prior to 2002-03) diagnosis fields in the HES data set and provides the main reason why the patient was admitted to hospital.</p><br /><p>[7]ICD-10 codes</p><p>The following ICD-10 codes were used to identify Obesity.</p><p><br> <br> <br> <br> <br> <br> <br></p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/12/2015 14:10:24 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

437892

registered interest
date	14/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Department of Health: Mobile Phones
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much (a) his Department, (b) Public Health England, (c) NHS England and (d) each non-departmental public body spent on downloading apps for smartphones and similar devices in each of the last five years.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	20001
answer	answer is ministerial correction date of answer 17/12/2015 answer text <br /><p>Information about the cost of downloading apps for smartphones and similar devices in the Department and its arm’s length bodies for each of the last five years is in the tables below.</p><p>The National Institute for Care and Excellence (NICE) is unable to provide a response to this question as it would incur disproportional cost to establish whether this information is held. We don’t have a separate expense code that would enable an easy search of this type of expenditure.</p><p>Health Education England do not collect this data. Applications are usually purchased by the individual and claimed back through expenses.</p><br /><table><tbody><tr><td><p>Organisation</p></td><td><p>Cost</p></td></tr><tr><td><p>Department of Health</p></td><td><p><br></p></td></tr><tr><td><p>2011-12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012-13</p></td><td><p>Nil</p></td></tr><tr><td><p>2013-14</p></td><td><p>Nil</p></td></tr><tr><td><p>2014-15</p></td><td><p>Nil</p></td></tr><tr><td><p>2015-16 to date</p></td><td><p>Nil</p></td></tr></tbody></table><br /><table><tbody><tr><td><p>Organisation</p></td><td><p>Cost</p></td></tr><tr><td><p>Care Quality Commission</p></td><td><p><br></p></td></tr><tr><td><p>2011-12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012-13</p></td><td><p>Nil</p></td></tr><tr><td><p>2013-14</p></td><td><p>Nil</p></td></tr><tr><td><p>2014-15</p></td><td><p>Nil</p></td></tr><tr><td><p>2015-16 to date</p></td><td><p>Nil</p></td></tr></tbody></table><br /><table><tbody><tr><td><p>Organisation</p></td><td><p>Cost</p></td></tr><tr><td><p>Human Fertilisation and Embryology Authority</p></td><td><p><br></p></td></tr><tr><td><p>2011-12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012-13</p></td><td><p>Nil</p></td></tr><tr><td><p>2013-14</p></td><td><p>Nil</p></td></tr><tr><td><p>2014-15</p></td><td><p>Nil</p></td></tr><tr><td><p>2015-16 to date</p></td><td><p>Nil</p></td></tr><tr><td><p><br></p></td><td><p><br></p></td></tr><tr><td><p>Organisation</p></td><td><p>Cost</p></td></tr><tr><td><p>Health and Social Care Information Centre</p></td></tr><tr><td><p>2011-12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012-13</p></td><td><p>Nil</p></td></tr><tr><td><p>2013-14</p></td><td><p>Nil</p></td></tr><tr><td><p>2014-15</p></td><td><p>Nil</p></td></tr><tr><td><p>2015-16 to date</p></td><td><p>Nil</p></td></tr></tbody></table><br /><table><tbody><tr><td><p>Organisation</p></td><td><p>Cost</p></td></tr><tr><td><p>Health Research Authority</p></td><td><p><br></p></td></tr><tr><td><p>2011-12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012-13</p></td><td><p>Nil</p></td></tr><tr><td><p>2013-14</p></td><td><p>Nil</p></td></tr><tr><td><p>2014-15</p></td><td><p>Nil</p></td></tr><tr><td><p>2015-16 to date</p></td><td><p>Nil</p></td></tr></tbody></table><br /><table><tbody><tr><td><p>Organisation</p></td><td><p>Cost</p></td></tr><tr><td><p>Human Tissue Authority</p></td><td><p><br></p></td></tr><tr><td><p>2011-12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012-13</p></td><td><p>Nil</p></td></tr><tr><td><p>2013-14</p></td><td><p>Nil</p></td></tr><tr><td><p>2014-15</p></td><td><p>Nil</p></td></tr><tr><td><p>2015-16 to date</p></td><td><p>Nil</p></td></tr></tbody></table><br /><table><tbody><tr><td><p>Organisation</p></td><td><p>Cost</p></td></tr><tr><td><p>Monitor</p></td><td><p><br></p></td></tr><tr><td><p>2011-12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012-13</p></td><td><p>Nil</p></td></tr><tr><td><p>2013-14</p></td><td><p>Nil</p></td></tr><tr><td><p>2014-15</p></td><td><p>Nil</p></td></tr><tr><td><p>2015-16 to date</p></td><td><p>Nil</p></td></tr></tbody></table><p><br></p><table><tbody><tr><td><p>Organisation</p></td><td><p>Cost</p></td></tr><tr><td><p>NHS England</p></td><td><p><br></p></td></tr><tr><td><p>2011-12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012-13</p></td><td><p>Nil</p></td></tr><tr><td><p>2013-14</p></td><td><p>Nil</p></td></tr><tr><td><p>2014-15</p></td><td><p>Nil</p></td></tr><tr><td><p>2015-16 to date</p></td><td><p>Nil</p></td></tr><tr><td><p><br></p></td><td><p><br></p></td></tr><tr><td><p>Organisation</p></td><td><p>Cost</p></td></tr><tr><td><p>Public Health England</p></td><td><p><br></p></td></tr><tr><td><p>2011-12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012-13</p></td><td><p>Nil</p></td></tr><tr><td><p>2013-14</p></td><td><p>Nil</p></td></tr><tr><td><p>2014-15</p></td><td><p>Nil</p></td></tr><tr><td><p>2015-16 to date</p></td><td><p>Nil</p></td></tr></tbody></table><br /><table><tbody><tr><td><p>Organisation</p></td><td><p>Cost</p></td></tr><tr><td><p>Health Research Authority</p></td><td><p><br></p></td></tr><tr><td><p>2011-12</p></td><td><p>Nil</p></td></tr><tr><td><p>2012-13</p></td><td><p>Nil</p></td></tr><tr><td><p>2013-14</p></td><td><p>Nil</p></td></tr><tr><td><p>2014-15</p></td><td><p>Nil</p></td></tr><tr><td><p>2015-16 to date</p></td><td><p>Nil</p></td></tr></tbody></table><p><br></p><p>NICE is unable to provide a response to this question as it would incur disproportional cost to establish whether this information is held. We don’t have a separate expense code that would enable an easy search of this type of expenditure.</p><br /><p>Health Education England do not collect this data. Applications are usually purchased by the individual and claimed back through expenses.</p><p><br> <br> <br> <br> <br> <br> <br></p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/12/2015 17:50:44 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

437893

registered interest
date	14/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sexually Transmitted Infections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many cases of (a) herpes, (b) chlamydia, (c) HIV, (d) syphilis and (e) gonorrhoea were diagnosed in people of each age group in each constituent region of the UK in each of the last five years.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	19901
answer	answer is ministerial correction date of answer 17/12/2015 answer text <p>While Public Health England (PHE) produces United Kingdom data tables for chlamydia, gonorrhoea and syphilis (primary, secondary and early latent), data for each of the constituent regions is held by respective devolved administrations. The data for England for these infections are presented in tables 1-4 for the most recent five complete calendar years (2010-2014).</p><br /><p>Data on new HIV diagnoses for the constituent regions of the UK are held by PHE and Tables 5-8 present data for the years 2010-2014 by constituent region, age group and year of diagnosis.</p><br /><p>The data provided relates to the number of diagnoses rather than incidence of infection, and as such an increase in the number of diagnoses could be attributable to increased testing rates rather than an increase in infections. For example, local authorities are encouraged to offer universal access to testing and treatment for chlamydia for young people age 15-24 as part of the National Chlamydia Screening Programme. Increases in chlamdyia screening provision will result in increasing infections detected.</p><p><br></p><p>Table 1: Anogenital herpes (first episode) diagnoses numbers in England by age group, 2010-14</p><table><tbody><tr><td><p>Age group</p></td><td><p>2010</p></td><td><p>2011</p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2014</p></td></tr><tr><td><p><br></p></td><td><p>46</p></td><td><p>60</p></td><td><p>50</p></td><td><p>53</p></td><td><p>46</p></td></tr><tr><td><p>15-19</p></td><td><p>4,155</p></td><td><p>4,295</p></td><td><p>4,258</p></td><td><p>4,032</p></td><td><p>4,096</p></td></tr><tr><td><p>20-24</p></td><td><p>8,204</p></td><td><p>8,881</p></td><td><p>9,130</p></td><td><p>9,136</p></td><td><p>8,863</p></td></tr><tr><td><p>25-34</p></td><td><p>9,579</p></td><td><p>9,996</p></td><td><p>10,439</p></td><td><p>10,687</p></td><td><p>10,685</p></td></tr><tr><td><p>35-44</p></td><td><p>4,460</p></td><td><p>4,495</p></td><td><p>4,402</p></td><td><p>4,506</p></td><td><p>4,187</p></td></tr><tr><td><p>45-64</p></td><td><p>3,060</p></td><td><p>3,222</p></td><td><p>3,295</p></td><td><p>3,655</p></td><td><p>3,556</p></td></tr><tr><td><p>65+</p></td><td><p>188</p></td><td><p>197</p></td><td><p>271</p></td><td><p>266</p></td><td><p>307</p></td></tr><tr><td><p>Other</p></td><td><p>6</p></td><td><p>8</p></td><td><p>19</p></td><td><p>14</p></td><td><p>37</p></td></tr><tr><td><p>Total</p></td><td><p>29,698</p></td><td><p>31,154</p></td><td><p>31,864</p></td><td><p>32,349</p></td><td><p>31,777[1]</p></td></tr></tbody></table><br /><p>[1] The Genitourinary Medicine Clinic Activity Dataset v2 (GUMCADv2) collects information on all STI diagnoses and services provided by GUM services in England. Data are published annually and provide information on trends in STI diagnoses and the provision of GUM services. Please see the following link for further information:</p><br /><p><a href="https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables" target="_blank">https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables</a></p><br /><p>Chlamydia data for England are sourced from GUM service GUMCADv2 returns &amp; data from community services. Data from community services are sourced from the National Chlamydia Screening Programme (NCSP) &amp; Non-NCSP/Non-GUM services for 2010-2011 &amp; only include those aged 15-24. Community services’ data from 2012 onwards are sourced from the Chlamydia Testing Activity Dataset (CTAD) &amp; include all ages. Therefore community services’ chlamydia data from 2012 onwards are not comparable to data from previous years. Chlamydia diagnoses from GUM services that were reported as ‘previously diagnosed at another service’ are excluded from data from 2012 onwards. These diagnoses have been reported via CTAD &amp; are already included in the community services’ data. Chlamydia testing and diagnosis data for 15-24 year olds who are resident in England is published quarterly and annually (calendar year) on the National Chlamydia Screening Programme (NCSP) website: <a href="https://www.gov.uk/government/statistics/national-chlamydia-screening-programme-ncsp-data-tables" target="_blank">https://www.gov.uk/government/statistics/national-chlamydia-screening-programme-ncsp-data-tables</a></p><br /><p>Table 2: Chlamydia diagnoses numbers in England by age group, 2012-14</p><table><tbody><tr><td><p>Age group</p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2014</p></td></tr><tr><td><p>13-14</p></td><td><p>1,017</p></td><td><p>1,081</p></td><td><p>885</p></td></tr><tr><td><p>15-19</p></td><td><p>61,044</p></td><td><p>60,533</p></td><td><p>57,268</p></td></tr><tr><td><p>20-24</p></td><td><p>82,602</p></td><td><p>82,030</p></td><td><p>81,222</p></td></tr><tr><td><p>25-34</p></td><td><p>46,173</p></td><td><p>47,278</p></td><td><p>49,311</p></td></tr><tr><td><p>35-44</p></td><td><p>11,061</p></td><td><p>10,890</p></td><td><p>11,627</p></td></tr><tr><td><p>45-64</p></td><td><p>4,968</p></td><td><p>4,940</p></td><td><p>5,399</p></td></tr><tr><td><p>65+</p></td><td><p>260</p></td><td><p>297</p></td><td><p>299</p></td></tr><tr><td><p>Other</p></td><td><p>672</p></td><td><p>802</p></td><td><p>763</p></td></tr><tr><td><p>Total</p></td><td><p>207,797</p></td><td><p>207,851</p></td><td><p>206,774</p></td></tr></tbody></table><p>Note: Data from 2012 onwards are not comparable to data from previous years</p><br /><p>Table 3: Syphilis diagnoses numbers (primary, secondary and early latent) in England by age group, 2010-14</p><table><tbody><tr><td><p>Age group</p></td><td><p>2010</p></td><td><p>2011</p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2014</p></td></tr><tr><td><p>13-14</p></td><td><p>0</p></td><td><p>1</p></td><td><p>1</p></td><td><p>2</p></td><td><p>0</p></td></tr><tr><td><p>15-19</p></td><td><p>84</p></td><td><p>87</p></td><td><p>79</p></td><td><p>95</p></td><td><p>93</p></td></tr><tr><td><p>20-24</p></td><td><p>334</p></td><td><p>364</p></td><td><p>397</p></td><td><p>341</p></td><td><p>445</p></td></tr><tr><td><p>25-34</p></td><td><p>842</p></td><td><p>977</p></td><td><p>986</p></td><td><p>1,083</p></td><td><p>1,421</p></td></tr><tr><td><p>35-44</p></td><td><p>772</p></td><td><p>883</p></td><td><p>805</p></td><td><p>908</p></td><td><p>1,288</p></td></tr><tr><td><p>45-64</p></td><td><p>557</p></td><td><p>557</p></td><td><p>642</p></td><td><p>756</p></td><td><p>997</p></td></tr><tr><td><p>65+</p></td><td><p>49</p></td><td><p>52</p></td><td><p>41</p></td><td><p>45</p></td><td><p>48</p></td></tr><tr><td><p>Other</p></td><td><p>9</p></td><td><p>6</p></td><td><p>8</p></td><td><p>6</p></td><td><p>25</p></td></tr><tr><td><p>Total</p></td><td><p>2,647</p></td><td><p>2,927</p></td><td><p>2,959</p></td><td><p>3,236</p></td><td><p>4,317</p></td></tr></tbody></table><p><br></p><p>Table 4: Gonorrhoea diagnoses numbers in England by age group, 2010-14</p><table><tbody><tr><td><p>Age group</p></td><td><p>2010</p></td><td><p>2011</p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2014</p></td></tr><tr><td><p>13-14</p></td><td><p>42</p></td><td><p>45</p></td><td><p>54</p></td><td><p>61</p></td><td><p>67</p></td></tr><tr><td><p>15-19</p></td><td><p>3,017</p></td><td><p>3,229</p></td><td><p>3,545</p></td><td><p>3,971</p></td><td><p>4,323</p></td></tr><tr><td><p>20-24</p></td><td><p>4,944</p></td><td><p>5,919</p></td><td><p>7,046</p></td><td><p>7,580</p></td><td><p>8,885</p></td></tr><tr><td><p>25-34</p></td><td><p>5,246</p></td><td><p>6,983</p></td><td><p>8,824</p></td><td><p>10,558</p></td><td><p>12,788</p></td></tr><tr><td><p>35-44</p></td><td><p>2,294</p></td><td><p>3,056</p></td><td><p>3,881</p></td><td><p>4,607</p></td><td><p>5,602</p></td></tr><tr><td><p>45-64</p></td><td><p>1,234</p></td><td><p>1,733</p></td><td><p>2,066</p></td><td><p>2,481</p></td><td><p>3,028</p></td></tr><tr><td><p>65+</p></td><td><p>54</p></td><td><p>91</p></td><td><p>108</p></td><td><p>126</p></td><td><p>165</p></td></tr><tr><td><p>Unknown</p></td><td><p>12</p></td><td><p>34</p></td><td><p>52</p></td><td><p>35</p></td><td><p>100</p></td></tr><tr><td><p>Total</p></td><td><p>16,843</p></td><td><p>21,090</p></td><td><p>25,576</p></td><td><p>29,419</p></td><td><p>34,958</p></td></tr></tbody></table><p><br></p><p>Table 5: HIV diagnoses numbers in England by age group and year, 2010-14</p><table><tbody><tr><td><p>Age at diagnosis</p></td><td><p>2010</p></td><td><p>2011</p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2014</p></td></tr><tr><td><p><br></p></td><td><p>63</p></td><td><p>64</p></td><td><p>39</p></td><td><p>32</p></td><td><p>25</p></td></tr><tr><td><p>15-24</p></td><td><p>623</p></td><td><p>601</p></td><td><p>641</p></td><td><p>701</p></td><td><p>666</p></td></tr><tr><td><p>25-34</p></td><td><p>1,883</p></td><td><p>1,868</p></td><td><p>1,784</p></td><td><p>1,801</p></td><td><p>1,851</p></td></tr><tr><td><p>35-44</p></td><td><p>1,879</p></td><td><p>1,753</p></td><td><p>1,747</p></td><td><p>1,524</p></td><td><p>1,429</p></td></tr><tr><td><p>45-54</p></td><td><p>955</p></td><td><p>945</p></td><td><p>1,040</p></td><td><p>977</p></td><td><p>1,008</p></td></tr><tr><td><p>55-64</p></td><td><p>319</p></td><td><p>322</p></td><td><p>350</p></td><td><p>314</p></td><td><p>388</p></td></tr><tr><td><p>65+</p></td><td><p>99</p></td><td><p>99</p></td><td><p>139</p></td><td><p>170</p></td><td><p>192</p></td></tr><tr><td><p>Total</p></td><td><p>5,821</p></td><td><p>5,652</p></td><td><p>5,740</p></td><td><p>5,519</p></td><td><p>5,559</p></td></tr></tbody></table><p><br></p><p>Table 6: HIV diagnoses numbers in Wales by age group and year, 2010-14</p><table><tbody><tr><td><p>Age at diagnosis</p></td><td><p>2010</p></td><td><p>2011</p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2014</p></td></tr><tr><td><p><br></p></td><td><p>0</p></td><td><p>0</p></td><td><p>1</p></td><td><p>1</p></td><td><p>2</p></td></tr><tr><td><p>15-24</p></td><td><p>23</p></td><td><p>19</p></td><td><p>20</p></td><td><p>19</p></td><td><p>20</p></td></tr><tr><td><p>25-34</p></td><td><p>49</p></td><td><p>50</p></td><td><p>30</p></td><td><p>41</p></td><td><p>55</p></td></tr><tr><td><p>35-44</p></td><td><p>42</p></td><td><p>41</p></td><td><p>35</p></td><td><p>32</p></td><td><p>46</p></td></tr><tr><td><p>45-54</p></td><td><p>25</p></td><td><p>33</p></td><td><p>19</p></td><td><p>30</p></td><td><p>44</p></td></tr><tr><td><p>55-64</p></td><td><p>10</p></td><td><p>10</p></td><td><p>12</p></td><td><p>7</p></td><td><p>13</p></td></tr><tr><td><p>65+</p></td><td><p>3</p></td><td><p>4</p></td><td><p>3</p></td><td><p>3</p></td><td><p>9</p></td></tr><tr><td><p>Total</p></td><td><p>152</p></td><td><p>157</p></td><td><p>120</p></td><td><p>133</p></td><td><p>189</p></td></tr></tbody></table><p><br> <br> <br></p><p>Table 7: HIV diagnoses numbers in Northern Ireland by age group and year, 2010-14</p><table><tbody><tr><td><p>Age at diagnosis</p></td><td><p>2010</p></td><td><p>2011</p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2014</p></td></tr><tr><td><p><br></p></td><td><p>1</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>15-24</p></td><td><p>10</p></td><td><p>9</p></td><td><p>14</p></td><td><p>6</p></td><td><p>14</p></td></tr><tr><td><p>25-34</p></td><td><p>29</p></td><td><p>29</p></td><td><p>37</p></td><td><p>29</p></td><td><p>24</p></td></tr><tr><td><p>35-44</p></td><td><p>24</p></td><td><p>21</p></td><td><p>22</p></td><td><p>25</p></td><td><p>31</p></td></tr><tr><td><p>45-54</p></td><td><p>20</p></td><td><p>15</p></td><td><p>9</p></td><td><p>24</p></td><td><p>18</p></td></tr><tr><td><p>55-64</p></td><td><p>2</p></td><td><p>5</p></td><td><p>13</p></td><td><p>8</p></td><td><p>5</p></td></tr><tr><td><p>65+</p></td><td><p>0</p></td><td><p>3</p></td><td><p>0</p></td><td><p>3</p></td><td><p>2</p></td></tr><tr><td><p>Total</p></td><td><p>86</p></td><td><p>82</p></td><td><p>95</p></td><td><p>95</p></td><td><p>94</p></td></tr></tbody></table><p><br></p><p>Table 8: HIV diagnoses numbers in Scotland by age group and year, 2010-14</p><table><tbody><tr><td><p>Age at diagnosis</p></td><td><p>2010</p></td><td><p>2011</p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2014</p></td></tr><tr><td><p><br></p></td><td><p>7</p></td><td><p>4</p></td><td><p>3</p></td><td><p>2</p></td><td><p>4</p></td></tr><tr><td><p>15-24</p></td><td><p>26</p></td><td><p>29</p></td><td><p>26</p></td><td><p>23</p></td><td><p>24</p></td></tr><tr><td><p>25-34</p></td><td><p>100</p></td><td><p>103</p></td><td><p>94</p></td><td><p>100</p></td><td><p>109</p></td></tr><tr><td><p>35-44</p></td><td><p>82</p></td><td><p>92</p></td><td><p>79</p></td><td><p>81</p></td><td><p>80</p></td></tr><tr><td><p>45-54</p></td><td><p>49</p></td><td><p>38</p></td><td><p>61</p></td><td><p>41</p></td><td><p>48</p></td></tr><tr><td><p>55-64</p></td><td><p>19</p></td><td><p>19</p></td><td><p>19</p></td><td><p>21</p></td><td><p>18</p></td></tr><tr><td><p>65+</p></td><td><p>5</p></td><td><p>3</p></td><td><p>4</p></td><td><p>5</p></td><td><p>6</p></td></tr><tr><td><p>Total</p></td><td><p>288</p></td><td><p>288</p></td><td><p>286</p></td><td><p>273</p></td><td><p>289</p></td></tr></tbody></table><p>[2]</p><br /><p>[2] Age group data presented in tables 1-4 are consistent with the Annual STI publication: <a href="https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables" target="_blank">https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables</a>. Age group category ‘65+’ includes those aged 65-99 only. Age group category ‘other’ includes those aged 0-12 &amp; those with an unknown age.</p><p>Data in tables 5-8 may change as further reports of HIV are received, at present data contains reports to the end of June 2015. Data include individuals who have an existing infection as well as those who have a newly acquired infection and therefore the data do not present incidence of infection. Areas presented reflect region of diagnosis, not of residence.</p><br /> <br /><p><br></p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/12/2015 14:50:32 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

437909

registered interest
date	14/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Everolimus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions his Department has had with Solutions for Public Health on developing a draft commissioning policy for everolimus.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	19902
answer	answer is ministerial correction date of answer 17/12/2015 answer text <p><strong></strong>NHS England has a service level agreement in place with Solutions for Public Health (SPH), a NHS public health unit which forms part of the NHS Arden and Greater East Midlands Commissioning Support Unit.</p><br /><p>NHS England has commissioned SPH to provide impartial clinical evidence reviews. These clinical evidence reviews are undertaken independently in line with an agreed methodology and are a critical component in informing evidence based clinical commissioning policies for directly commissioned specialised services, based on the latest published research.</p><br /><p>However, SPH does not have any subsequent involvement in the development, drafting or consideration of NHS England’s clinical commissioning policies.</p><br /><p><strong></strong></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 17/12/2015 16:29:24 answering member 4020 label Biography information for George Freeman
tabling member	1540 label Biography information for Greg Mulholland

437910

registered interest
date	14/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Everolimus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions Solutions for Public Health has had with the European Medicines Agency and US Food and Drug Administration on developing a draft commissioning policy for everolimus.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	19903
answer	answer is ministerial correction date of answer 17/12/2015 answer text <p>Solutions for Public Health has confirmed that they have not had any discussions with either the European Medicines Agency or US Food and Drug Administration in relation to Everolimus.</p><br /><p>This is outside of the scope of the evidence review methodology commissioned by NHS England and would not be relevant to their role as a provider of stand-alone clinical evidence reviews.</p><p><strong></strong></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 17/12/2015 16:28:10 answering member 4020 label Biography information for George Freeman
tabling member	1540 label Biography information for Greg Mulholland

437911

registered interest
date	14/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tuberous Sclerosis: Everolimus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps NHS England is taking to develop an in-year draft commissioning policy for the use of everolimus to treat tuberous sclerosis complex.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	19896
answer	answer is ministerial correction date of answer 17/12/2015 answer text <p><strong></strong></p><br /><p>NHS England is currently developing a clinical commissioning policy statement to cover the use of Everolimus in adults with angiomyolipoma in association with tuberous sclerosis complex, as part of its in-year policy work programme.</p><br /><p>In common with its standard process, NHS England has formed a policy working group and commissioned a clinical evidence review. This is now complete and is informing the development of a draft policy statement. The draft policy statement, along with the evidence review, will be shared and tested with stakeholders prior to formal consideration by NHS England in early 2016. The policy statement will be published in due course.</p><br /><p>In the meantime, NHS England will continue to consider funding this treatment for individual patients in clinically exceptional and/or critically urgent clinical circumstances.</p><br /><p><strong></strong></p><p><strong></strong></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 17/12/2015 16:17:20 answering member 4020 label Biography information for George Freeman
tabling member	1540 label Biography information for Greg Mulholland

437912

registered interest
date	14/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Solutions for Public Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the budget of Solutions for Public Health has been in each of the last three years.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	19921
answer	answer is ministerial correction date of answer 17/12/2015 answer text <p><strong></strong>NHS England is unable to comment on the overall budgetary position of Solutions for Public Health (SPH). However, NHS England anticipates spending around £485,000 with SPH for the provision of stand-alone clinical evidence reviews in support of its specialised services clinical commissioning policy work plan in 2015/16.</p><br /><p>Equivalent expenditure with SPH in 2014/15 was £285,000 and £190,000 in 2013/14.</p><p><strong></strong></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 17/12/2015 16:11:14 answering member 4020 label Biography information for George Freeman
tabling member	1540 label Biography information for Greg Mulholland

437913

registered interest
date	14/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Solutions for Public Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what mechanisms his Department has for quality assurance of the work of Solutions for Public Health.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	19922
answer	answer is ministerial correction date of answer 17/12/2015 answer text <p>It is the responsibility of NHS England to quality assure the work of Solutions for Public Health (SPM).</p><br /><p>NHS England has a service level agreement in place with SPM and this sets out the terms under which stand-alone clinical evidence reviews are conducted and completed. The agreed methodology is based on best practice within the health sector and the collective experience of experts in public health and clinical effectiveness.</p><br /><p>As additional assurance, draft evidence reviews are tested prior to their completion with members of NHS England’s clinical reference groups, which include clinical and patient experts relevant to the service or speciality concerned from across England. Evidence reviews are also now shared as part of both informal stakeholder testing and formal public consultation alongside the draft clinical commissioning policies that they have informed.</p><p><strong></strong></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 17/12/2015 16:13:54 answering member 4020 label Biography information for George Freeman
tabling member	1540 label Biography information for Greg Mulholland